Down 28.2% in 4 Weeks, Here's Why You Should You Buy the Dip in Microbot Medical (MBOT)
Microbot Medical® to Commercially Debut the LIBERTY® System at The Symposium on Clinical Interventional Oncology Annual Meeting
Product StageManagement Changes
Microbot Medical® Secures U.S. Based Logistics Partner to Support the Commercialization of Its LIBERTY® Endovascular Robotic System
Product StagePartners
Microbot Medical Announces Final Closing of Exercise of Outstanding Preferred Investment Options of Up to $92.2 Million in Gross Proceeds
Investment
Microbot Medical® Receives First Patent in Japan as it Continues to Broaden its Global Intellectual Property Portfolio
Product StageFDA approvedExpand
All You Need to Know About Microbot Medical (MBOT) Rating Upgrade to Buy
Miocrbot Medical® CEO to Discuss Recent FDA Clearance of the LIBERTY® Endovascular Robotic System
Product StageFDA approved/pending approval
Microbot (MBOT) Extends 4-Day Decline on $63-Million Fundraising Program
Investment
Why Microbot Medical (MBOT) Is Up After FDA Clears LIBERTY System and $92M Funding Announced
Product StageInvestment
Microbot Medical Announces First Closing of Exercise of Outstanding Preferred Investment Options of Up to $92.2 Million in Gross Proceeds
Investment
Microbot Medical Announces Exercise of Outstanding Preferred Investment Options for Up to $92.2 Million in Gross Proceeds
Investment
Microbot Shares Rise on FDA Clearance for LIBERTY Robotic System
Product StageFDA approved/pending approval
Microbot receives 510(k) clearance for endovascular robot
Product StageInvestment
REMINDER: Microbot Medical to Highlight FDA 510(k) Clearance of the LIBERTY Endovascular Robotic System at the H.C. Wainwright Annual Investor Conference
FDA approved/pending approval
Microbot Medical® Receives FDA 510(k) Clearance for Its LIBERTY® Endovascular Robotic System
Product StageFDA approved/pending approval
Microbot Shares Rise as New U.S. Patent Expands LIBERTY System Market
Product StageFDA approved/pending approval
Microbot Medical® Granted U.S. Patent that Significantly Expands Potential Market Applications
Product Stage
DIH Appoints Scott R. Burell to DIH Holding US, Inc. Board of Directors
Management Changes
Microbot Medical secures grant for endovascular robotic system
InvestmentProduct StagePartners
Microbot Medical® Receives Non-Dilutive Grant to Enhance Operational Capabilities
InvestmentFDA approved/pending approvalPartners
+ 143 more articles
